121 related articles for article (PubMed ID: 7931254)
1. The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; Yuwiler A; Palfreyman MG
J Neural Transm Suppl; 1994; 41():377-9. PubMed ID: 7931254
[TBL] [Abstract][Full Text] [Related]
2. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
[TBL] [Abstract][Full Text] [Related]
3. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; McIntyre IM; White K
J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
[TBL] [Abstract][Full Text] [Related]
5. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
Oxenkrug GF; Requintina PJ; Yuwiler A
J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
[TBL] [Abstract][Full Text] [Related]
6. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
[TBL] [Abstract][Full Text] [Related]
7. Chronopharmacological study of moclobemide effect on the rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; White K; Yuwiler A
J Neural Transm Suppl; 1994; 41():335-7. PubMed ID: 7931247
[TBL] [Abstract][Full Text] [Related]
8. Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition.
King TS; Richardson BA; Reiter RJ
Mol Cell Endocrinol; 1982 Mar; 25(3):327-38. PubMed ID: 6279462
[TBL] [Abstract][Full Text] [Related]
9. The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats.
Oxenkrug GF; Requintina PJ; Correa RM; Yuwiler A
J Neural Transm Suppl; 1994; 41():249-52. PubMed ID: 7931233
[TBL] [Abstract][Full Text] [Related]
10. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
[TBL] [Abstract][Full Text] [Related]
11. The effect of isatin (tribulin) on metabolism of indoles in the rat brain and pineal: in vitro and in vivo studies.
Yuwiler A
Neurochem Res; 1990 Jan; 15(1):95-100. PubMed ID: 1691454
[TBL] [Abstract][Full Text] [Related]
12. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
Treseder SA; Rose S; Summo L; Jenner P
J Neural Transm (Vienna); 2003 Mar; 110(3):229-38. PubMed ID: 12658372
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
[TBL] [Abstract][Full Text] [Related]
14. Carbidopa effect on rat brain monoamine oxidase and pineal melatonin.
McIntyre IM; McCauley RB; Filipowicz C; Oxenkrug GF
Biol Psychiatry; 1985 Jul; 20(7):809-11. PubMed ID: 4005339
[No Abstract] [Full Text] [Related]
15. MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
Zreika M; Fozard JR; Dudley MW; Bey P; McDonald IA; Palfreyman MG
J Neural Transm Park Dis Dement Sect; 1989; 1(4):243-54. PubMed ID: 2597310
[TBL] [Abstract][Full Text] [Related]
16. The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats.
Oxenkrug GF; McIntyre IM; Requintina PJ; Duffy JD
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):895-902. PubMed ID: 1722343
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
Fagervall I; Ross SB
J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
[TBL] [Abstract][Full Text] [Related]
18. [N-acetylserotonin and hypotensive effect of MAO-A inhibitors].
Oxenkrug GF
Vopr Med Khim; 1997; 43(6):522-6. PubMed ID: 9503569
[TBL] [Abstract][Full Text] [Related]
19. The effect of MAO-A inhibition and cold-immobilization stress on N-acetylserotonin and melatonin in SHR and WKY rats.
Oxenkrug GF; Requintina PJ
J Neural Transm Suppl; 1998; 52():333-6. PubMed ID: 9564635
[TBL] [Abstract][Full Text] [Related]
20. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.
Henriot S; Kuhn C; Kettler R; Da Prada M
J Neural Transm Suppl; 1994; 41():321-5. PubMed ID: 7931245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
